
3つのファイルの最後の条文は以下の通りです。

mta_ukbb_1-3.md: 3.9 For the avoidance of doubt, the rights granted under this MTA to the Applicant to use the Materials are for the Permitted Purpose only.

mta_ega.md: 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.

mta_nih.md: 10. Miscellaneous

UK Biobank (UKBB) と他のMTAの比較
1. Supply of Materials by UK Biobank

対応するEGAの条文はありません

対応するNIHの条文はありません

1.1 UK Biobank agrees to supply the Materials to the Applicant in the timeframe and manner set out in this MTA, subject to the provisions of this MTA.

対応するEGAの条文はありません

対応するNIHの条文はありません

1.2 UK Biobank warrants to the Applicant that for the purposes of this MTA:

対応するEGAの条文はありません

対応するNIHの条文はありません

1.2.1 it is entitled to supply the Materials to the Applicant;

対応するEGAの条文はありません

対応するNIHの条文はありません

1.2.2 consent to take part in UK Biobank has been obtained from the Participants and further, consent under the Human Tissue Act 2004, has been obtained from the relevant Participants; and

対応するEGAの条文はありません

対応するNIHの条文はありません

1.2.3 the use of the Materials for the Approved Research Project falls within UK Biobank's generic Research Tissue Bank (RTB) approval from the NHS North West REC, available here.

対応するEGAの条文はありません

対応するNIHの条文はありません

1.3 The Applicant agrees that the Materials are provided on an "as is" basis without any warranty of satisfactory quality or fitness for a particular purpose or use, or that use of the Materials shall not infringe the rights of any third party. Except as expressly stated in this MTA, all warranties, terms and conditions, whether express or implied by statute, common law or otherwise, are excluded to the fullest extent permitted by law.

対応するEGAの条文：6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipients use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data.

比較結果：一致

判断理由：UKBBとEGAの条文は、データの提供者側がデータの品質や利用目的への適合性について一切の保証をせず、利用によって生じるいかなる損害についても責任を負わないとする内容で一致しています。

対応するNIHの条文：6. Disclaimer [May consider including a disclaimer of warranties related to the accuracy, integrity, reliability, or completeness of data, as well as a disclaimer of standard warranties of title, non- infringement, merchantability, fitness for a particular purpose. May also consider adding language so it is clear that underlying registry data contributors have no responsibilities regarding the Data.]

比較結果：一致

判断理由：UKBBの条文とNIHの条文は、データの正確性、完全性、信頼性、非侵害性など、データに関するあらゆる保証を否認する内容で一致しています。

2. Usage of Materials by the Applicant

対応するEGAの条文はありません

対応するNIHの条文はありません

2.1 The Applicant agrees that the Materials:

対応するEGAの条文はありません

対応するNIHの条文はありません

2.1.1 shall only be used in accordance with the terms and conditions of this MTA;

対応するEGAの条文はありません

対応するNIHの条文：1. Permitted Uses of Data

比較結果：部分一致

判断理由：UKBBはMTAの条項に従ってのみ使用されることを定めており、NIHは許可された用途に関する条項全体を定めています。NIHの条文がより広範です。

2.1.2 shall only be used to conduct the Approved Research Project for the Permitted Purpose only;

対応するEGAの条文：1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes.

比較結果：一致

判断理由：UKBBとEGAは、提供されたデータを特定のプロジェクトおよび許可された目的のためにのみ使用することに同意する点で一致しています。

対応するNIHの条文：1.b. Researcher shall use the Data solely to perform the Research (and related activities) described in Exhibit B attached to this Agreement (the "Research"). Any other uses are strictly prohibited without the express prior written permission of Registry. To conduct additional or different research, Researcher must submit a separate proposal to Registry. Any such additional/different research must be approved by Registry and set forth in either an amendment to this Agreement or a subsequent data use agreement with Registry.

比較結果：一致

判断理由：UKBBとNIHは、データが特定の研究目的のためのみに使用されるべきであり、他の用途は明示的に禁止されているという点で一致しています。

2.1.3 shall not be used for any purpose connected with prohibited weapons (including biological weapons), and shall not be transferred if it is known or suspected that they are intended or likely to be used for such purposes;

対応するEGAの条文はありません

対応するNIHの条文：1.i. [May consider inserting other restrictions that may be desirable, e.g., prohibitions on using the Data for specific purposes, use of Data within specific geographic locations only]

比較結果：不一致

判断理由：UKBBは特定の禁止事項（兵器関連）を明記していますが、NIHは一般的な禁止事項の可能性に言及しているだけで、具体的な内容は記載されていません。

2.1.4 shall not be transferred to a destination subject to a UN, EU, UK or OSCE embargo where that act would be in breach of the terms of that embargo; and

対応するEGAの条文はありません

対応するNIHの条文はありません

2.1.5 shall only be used by the Applicant institution and on an individual level within the Applicant, by the Applicant Pl, the Applicant Researchers and by Affiliates and Third-Party Processors (appointed by the Applicant).

対応するEGAの条文：5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data.

比較結果：一致

判断理由：UKBBとEGAは、データの使用を許可された個人や組織内の許可された人員に限定するという点で一致しています。

対応するNIHの条文：1.g. Researcher may make available the Data only to those persons expressly identified as Research personnel in Exhibit B. Any other personnel may require an amendment to this Agreement or a separate data use agreement with Registry.

比較結果：一致

判断理由：UKBBとNIHは、データが同意書に明記された研究者や職員のみに利用可能であるという点で一致しています。

2.2 The Applicant shall not share, sub-license, disclose, transfer, sell, gift or supply the Materials to any other person or unauthorised third party.

対応するEGAの条文：5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel.

比較結果：部分一致

判断理由：UKBBはデータの共有、サブライセンス、開示、譲渡、販売、提供を禁止していますが、EGAは許可された人員への譲渡または開示のみを認めています。UKBBの禁止事項がより広範です。

対応するNIHの条文：1.e. Researcher shall use appropriate safeguards to prevent use or disclosure of the Data other than as provided by this Agreement. Researcher shall notify Registry within [may consider inserting a specific timeframe, e.g., two (2) business days, or a more general requirement, e.g., immediately/promptly upon discovery] of any uses or disclosures of Data not permitted by this Agreement.

比較結果：部分一致

判断理由：UKBBはデータの共有や譲渡を具体的に禁止していますが、NIHは許可されていない使用や開示を防ぐための適切な保護措置を取ることを要求しており、内容は似ていますが直接的な禁止事項ではありません。

2.3 Without prejudice to the other provisions of this MTA, any actual or anticipatory breach of any provision of clauses 2.1 or 2.2 shall entitle UK Biobank to terminate this Agreement with immediate effect and require the immediate return or destruction of any Materials provided by UK Biobank.

対応するEGAの条文：15. XXXXX may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements.

比較結果：部分一致

判断理由：UKBBは2.1または2.2の条項違反の場合に即時終了とデータ破棄を定めています。EGAは理由を問わず書面通知による終了とデータ破棄を定めており、違反時に限定していません。

対応するNIHの条文：8.b. Termination: ... In addition, either party may terminate this Agreement upon written notice to the other party in the event of a material breach of this Agreement by the other party, which material breach is not cured within [insert number] days after receipt of written notice thereof.

比較結果：部分一致

判断理由：UKBBは即時終了権を定めていますが、NIHは重大な違反があった場合に通知後一定期間が経過しても是正されない場合に終了できるとしており、即時終了ではありません。

2.4 The Applicant shall and shall procure cure that the Applicant Pl, the Applicant Researchers and any Affiliate and any Third-Party Processors are made aware of, and shall comply with, the terms and conditions of this MTA and the Data Protection Legislation. Any act or omission of the Applicant Pl or any Applicant Researcher or any Affiliate or any Third-Party Processor shall be deemed to be an act of the relevant Applicant for which the relevant Applicant is fully responsible and liable.

対応するEGAの条文：18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement.

比較結果：一致

判断理由：UKBBとEGAは、研究機関がMTAの条項を承認された担当者に周知させ、担当者がその条項を遵守するように手配することに同意しています。

対応するNIHの条文：1.c. Researcher shall perform the Research and use the Data in strict compliance with: (i) this Agreement; (ii) all applicable laws, rules and regulations...

比較結果：部分一致

判断理由：UKBBは研究者が責任を負うことを明記していますが、NIHは研究者が契約と法律に厳密に従うべきと述べているだけで、研究機関が職員に遵守させる責任について直接言及していません。

2.5 This MTA confers on the Applicant only those rights that are expressly granted to the Applicant.

対応するEGAの条文はありません

対応するNIHの条文はありません

2.6 In relation to the Materials supplied to the Applicant:

対応するEGAの条文はありません

対応するNIHの条文はありません

2.6.1 UK Biobank is the owner of the Materials, and UK Biobank is the owner of the Intellectual Property Rights in the Materials; and

対応するEGAの条文はありません

対応するNIHの条文：7.a. All Data is and shall remain the sole and exclusive property of Registry. No ownership rights in or to the Data are transferred to Researcher hereunder.

比較結果：一致

判断理由：UKBBとNIHは、データ提供者がデータの唯一かつ排他的な所有者であり、利用者に所有権は移転されないという点で一致しています。

2.6.2 UK Biobank hereby grants to the Applicant a revocable, worldwide, royalty-free, non-exclusive, non-transferable licence (but not any ownership rights) during the Term to use the Materials for the Permitted Purpose, subject to the terms and conditions of this MTA.

対応するEGAの条文はありません

対応するNIHの条文：1.a. Registry hereby grants to Researcher the right to access and use the Data for the purpose expressly set forth in this Agreement.

比較結果：部分一致

判断理由：UKBBは、取り消し可能、ロイヤリティフリー、非独占的なライセンスを付与すると詳細に述べていますが、NIHは単にアクセスして使用する権利を付与すると述べているだけで、ライセンスの条件については詳しく言及していません。

3. Generation of data by the Applicant

対応するEGAの条文はありません

対応するNIHの条文はありません

3.1 The data generated by the Applicant in the performance of the Approved Research Project shall be deemed to fall into the following categories:

対応するEGAの条文はありません

対応するNIHの条文はありません

3.1.1 Results Data: data and methodology (for example, the SAS/R/Stata scripts) which underlie the Findings, and which would enable another competent researcher to generate the Findings;

対応するEGAの条文はありません

対応するNIHの条文はありません

3.1.2 Findings: the findings generated by the Applicant as a result of the Approved Research Project; and/or

対応するEGAの条文はありません

対応するNIHの条文はありません

3.1.3 Other Data: all other data generated by the Applicant which is not in one of the above two categories.

対応するEGAの条文はありません

対応するNIHの条文はありません

3.2 Except as provided in clause 3.3, the Applicant shall own the IPRs in their Findings, the Results Data and the Other Data. The Applicant hereby grants a perpetual, irrevocable, worldwide, fully paid up, royalty free, fully sub-licensable non-exclusive licence to UK Biobank to use, reproduce, distribute, publish, store and otherwise disseminate the Findings, the Results Data and the Other Data.

対応するEGAの条文：9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data.

比較結果：不一致

判断理由：UKBBは申請者が派生データのIPRを所有し、UKBBにライセンスを付与することを定めていますが、EGAは利用者が知的財産権の主張を行わないことに同意する内容で、所有権とライセンスに関する規定ではありません。

対応するNIHの条文：7.d. [If inventions are contemplated, may consider adding applicable invention ownership/rights language.]

比較結果：不一致

判断理由：UKBBは生成されたデータのIPR所有権とライセンスについて詳細に述べていますが、NIHは発明が想定される場合の所有権条項を追加する可能性に言及しているだけで、具体的な規定はありません。

3.3 Nothing in this MTA shall operate to assign to the Applicant any IPRs in the Materials.

対応するEGAの条文はありません

対応するNIHの条文：7.a. All Data is and shall remain the sole and exclusive property of Registry. No ownership rights in or to the Data are transferred to Researcher hereunder.

比較結果：一致

判断理由：UKBBは元の資料のIPRが申請者に譲渡されないことを明記しており、NIHはデータへの所有権が研究者に移転されないことを明記しています。

3.4 The Applicant confirms to UK Biobank that UK Biobank's receipt of and use of the Applicant's Findings and Results Data shall not infringe the rights, including any existing IPRS, of any third party. Such confirmation shall be:

対応するEGAの条文はありません

対応するNIHの条文はありません

3.4.1 deemed to be taken at the time, respectively, of the publication of the Findings or the return of the Results Data to UK Biobank; and

対応するEGAの条文はありません

対応するNIHの条文はありません

3.4.2 given to the best of the Applicant's knowledge and belief, having made reasonable and diligent enquiry (but the extent of this obligation does not include any requirement on the Applicant to conduct external patent searches).

対応するEGAの条文はありません

対応するNIHの条文はありません

3.5 Subject always to the restriction in clause 3.7, UK Biobank confirms that it shall have no rights or licence to the IPRs in relation to any inventions made by the Applicant as a result of using the Materials, Results Data, Findings or Other Data ("Applicant-Generated Inventions").

対応するEGAの条文：10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf).

比較結果：一致

判断理由：UKBBとEGAは、利用者が提供されたデータを使用して行われた発明に対する知的財産権を取得できる可能性を認めており、その後の研究を妨げないようにライセンスポリシーを実施することに同意しています。

対応するNIHの条文：7.d. [If inventions are contemplated, may consider adding applicable invention ownership/rights language.]

比較結果：部分一致

判断理由：UKBBは発明に関するIPRについて具体的な言及をしていますが、NIHは発明が想定される場合に所有権/権利の文言を追加することを検討する可能性に触れているだけで、具体的な規定はありません。

3.6 However, the Applicant acknowledges that the UK Biobank resource has been produced using a combination of the goodwill and contribution of 500,000 UK participants, charitable and public funding, the use of public resources (such as UK health-record data) and established with the express purpose of promoting the conduct of health-related research which is in the public interest.

対応するEGAの条文はありません

対応するNIHの条文はありません

3.7 Taking into account the acknowledgements in clause 3.6, the Applicant agrees that it shall not and shall not attempt to:

対応するEGAの条文はありません

対応するNIHの条文はありません

3.7.1 file any patents with claims directed to; or

対応するEGAの条文はありません

対応するNIHの条文はありません

3.7.2 otherwise seek to claim or enforce any IPRs in; the genotype-phenotype data within the Materials or in the genotype-phenotype data which has been generated by the Applicant in the course of the Approved Research Project.

対応するEGAの条文：9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data.

比較結果：一致

判断理由：UKBBとEGAは、利用者が提供されたデータ（ジェノタイプ・フェノタイプデータを含む）について知的財産権の主張を行わないことに同意する点で一致しています。

対応するNIHの条文はありません

3.8 UK Biobank expressly excludes any right of the Applicant to sub-licence any of the rights granted to the Materials under this MTA or to publish or distribute any of the Materials, except for the sole purpose of including a commensurate amount of supporting data in the Applicant's publication of its Findings.

対応するEGAの条文：5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel.

比較結果：部分一致

判断理由：UKBBはデータのサブライセンスと配布を具体的に禁止していますが、EGAはデータを許可された人員にのみ転送または開示することに同意する内容で、サブライセンスに関する直接的な言及はありません。

対応するNIHの条文はありません

3.9 For the avoidance of doubt, the rights granted under this MTA to the Applicant to use the Materials are for the Permitted Purpose only.

対応するEGAの条文：1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes.

比較結果：一致

判断理由：UKBBとEGAは、提供されたデータの使用が特定の許可された目的に限定されるという点で一致しています。

対応するNIHの条文：1.b. Researcher shall use the Data solely to perform the Research (and related activities) described in Exhibit B attached to this Agreement (the "Research").

比較結果：一致

判断理由：UKBBとNIHは、データが特定の研究目的のためのみに使用されるべきであるという点で一致しています。

UKBBに対応しなかったEGAの条文とNIHの条文の比較
1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I.

対応するNIHの条文：1.b. Researcher shall use the Data solely to perform the Research (and related activities) described in Exhibit B attached to this Agreement (the "Research").

比較結果：一致

判断理由：EGAとNIHは、データが特定の研究プロジェクトと目的に限定して使用されることに同意しています。

2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data.

対応するNIHの条文：7.b. Researcher agrees that it will not disclose to others or use for its own benefit or the benefit of others, any Data or other Confidential Information disclosed by Registry in the course of this Agreement.

比較結果：部分一致

判断理由：EGAはデータの機密性を維持し、研究参加者の機密情報を侵害しないことに焦点を当てていますが、NIHは研究者によるデータの開示を禁止し、機密情報を保護することに焦点を当てています。

3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification.

対応するNIHの条文：9. Publications [Registry may insert its desired publication requirements or otherwise attach or cross-reference its policy governing publications].

比較結果：部分一致

判断理由：EGAは出版物において研究参加者の機密性を保護することに具体的に言及していますが、NIHは出版に関する要件を追加する可能性に言及しているだけで、具体的な内容はありません。

4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction.

対応するNIHの条文：3.b. [Depending on the nature of the Data, it may be advisable to add detailed security requirements for Researcher to follow, e.g., use of encryption, password security requirements, separation of Data from other datasets, linking Data with other datasets. Security requirements also may be set forth in a Registry policy cross-referenced here].

比較結果：部分一致

判断理由：EGAはデータの結合や再識別を具体的に禁止していますが、NIHはデータの結合に関するセキュリティ要件を検討する可能性に言及しているだけで、具体的な禁止事項ではありません。

5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data.

対応するNIHの条文：1.g. Researcher may make available the Data only to those persons expressly identified as Research personnel in Exhibit B. Any other personnel may require an amendment to this Agreement or a separate data use agreement with Registry.

比較結果：一致

判断理由：EGAとNIHは、データへのアクセスを、事前に許可された人員に限定することに同意しています。

7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data.

対応するNIHの条文：9. Publications [Registry may insert its desired publication requirements or otherwise attach or cross-reference its policy governing publications].

比較結果：部分一致

判断理由：EGAは具体的なガイドラインの遵守と貢献の謝辞を求めていますが、NIHは出版に関する要件を追加する可能性に言及するだけで、具体的な内容は記載していません。

8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data.

対応するNIHの条文：9. Publications [Registry may insert its desired publication requirements or otherwise attach or cross-reference its policy governing publications].

比較結果：部分一致

判断理由：EGAは特定の出版ポリシー（モラトリアム期間を含む）の遵守を求めていますが、NIHは出版に関する要件を追加する可能性に言及しているだけで、具体的な内容は記載していません。

9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data.

対応するNIHの条文はありません

10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf).

対応するNIHの条文：7.d. [If inventions are contemplated, may consider adding applicable invention ownership/rights language.]

比較結果：部分一致

判断理由：EGAは知的財産権の取得とライセンスポリシーに関する具体的なガイドラインへの準拠を求めていますが、NIHは同様の規定を追加する可能性に言及するのみです。

11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements.

対応するNIHの条文：8.c. Effect of Termination: [Insert the Registry's requirement for post-termination activities, e.g., will Data need to be returned or destroyed, can Researcher continue using the Data for a limited period].

比較結果：一致

判断理由：EGAとNIHは、プロジェクト終了後のデータの破棄または返却について規定しています。

12. The User Institution will notify XXXXX within 30 days of any changes or departures of Authorised Personnel.

対応するNIHの条文はありません

13. The User Institution will notify XXXXX prior to any significant changes to the protocol for the Project.

対応するNIHの条文：1.b. To conduct additional or different research, Researcher must submit a separate proposal to Registry. Any such additional/different research must be approved by Registry and set forth in either an amendment to this Agreement or a subsequent data use agreement with Registry.

比較結果：一致

判断理由：EGAとNIHは、プロジェクトの変更（EGAでは「Significant changes to the protocol」、NIHでは「additional or different research」）について、事前に通知し承認を得ることを求めています。

14. The User Institution will notify XXXXX as soon as it becomes aware of a breach of the terms or conditions of this agreement.

対応するNIHの条文：1.e. Researcher shall notify Registry within [may consider inserting a specific timeframe, e.g., two (2) business days, or a more general requirement, e.g., immediately/promptly upon discovery] of any uses or disclosures of Data not permitted by this Agreement.

比較結果：一致

判断理由：EGAとNIHは、利用者が契約違反を認識した際に、提供者へ通知することを求めています。

15. XXXXX may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements.

対応するNIHの条文：8.b. Termination: Either party may terminate this Agreement upon [insert number] days prior written notice to the other party for any reason or no reason. Registry may terminate this Agreement immediately upon written notice to Researcher if Registry is no longer permitted to share the Data with Researcher.

比較結果：一致

判断理由：EGAとNIHは、書面による通知で契約を終了できることを規定しています。

16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than XXXXX. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement.

対応するNIHの条文はありません

17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement.

対応するNIHの条文：1.h. Registry (or its agents) may audit Researcher's use of the Data to ensure compliance with this Agreement. Any such audits will be conducted during Researcher's regular business hours with reasonable advanced notice and consideration for Researcher's business operations. Researcher will cooperate, and will ensure that all Researcher personnel will cooperate, with the auditors and will make all records and materials available to them.

比較結果：一致

判断理由：EGAとNIHは、提供者が監査を通じて契約遵守を確認する権利を有しており、利用者がそれに協力することを規定しています。

18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement.

対応するNIHの条文はありません

19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.

対応するNIHの条文：10. Miscellaneous [Registry may consider adding customary contract boilerplate, such as clauses related to assignment, notices, survival, counterparts, force majeure.]

比較結果：不一致

判断理由：EGAは準拠法と裁判管轄を具体的に定めていますが、NIHは慣習的な条項として言及しているだけで、具体的な内容は記載していません。

UKBBにもEGAにも対応しなかったNIHの条文
2. Cost Jor No Cost

2.a. Registry is making the Data available to Researcher at no cost to Researcher. [If payment is desired, it may be beneficial to add payment terms, e.g., invoicing procedure, payment due dates].

2.b. Researcher bears all costs and expenses incurred by Researcher to access and use the Data, and conduct the Research.

3. Representations of Researcher

3.a. Researcher represents and warrants that (i) it is duly incorporated or organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization; (ii) it has the power, authority and legal right to enter into this Agreement and to perform the activities contemplated hereunder, and that it has taken all necessary corporate action to authorize execution of this Agreement to the extent required; (iii) it has obtained or will obtain, to the extent required, all necessary consents, approvals and authorizations of governmental or regulatory authorities required to be obtained related to the performance of this Agreement and the Research; and (iv) the execution and delivery of this Agreement will not conflict with or violate any requirement of any applicable law or regulation and does not conflict with or constitute a default under any contractual obligation enforceable against it.

4. Limitation of Liability

5. Indemnification

7. Data Ownership; Confidentiality

7.b. Researcher agrees that it will not disclose to others or use for its own benefit or the benefit of others, any Data or other Confidential Information disclosed by Registry in the course of this Agreement. For purposes of this Agreement, "Confidential Information" shall mean methods, processes, know-how, policies, procedures, templates, and other non-public confidential information of Registry. All Confidential Information is and shall remain the confidential property of Registry. Researcher shall keep the Confidential Information in strict confidence and may not use or otherwise disclose the Confidential Information to any third party without the prior written consent of Registry. Researcher shall notify Registry within [insert timeframe, e.g., two (2) business days] of any uses or disclosures of Confidential Information not permitted by this Agreement.

8. Term and Termination

8.a. Term: The term of this Agreement shall commence on the Effective Date and, unless earlier terminated as set forth in this Section 8, shall remain in effect [may consider a specified term; e.g., set number of years, or a broader end date, e.g., until completion of the Research].

10. Miscellaneous